Cargando…

Determinants to optimize response to clopidogrel in acute coronary syndrome

The inhibition of platelet function by antiplatelet therapy determines the improvement of the survival of patients with clinically evident cardiovascular disease. Clopidogrel in combination with aspirin is the recommended standard of care for reducing the occurrence of cardiovascular events in patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giusti, Betti, Gori, Anna Maria, Marcucci, Rossella, Saracini, Claudia, Vestrini, Anna, Abbate, Rosanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513207/ https://www.ncbi.nlm.nih.gov/pubmed/23226041

Ejemplares similares

Inflammatory and Antioxidant Pattern Unbalance in “Clopidogrel-Resistant” Patients during Acute Coronary Syndrome
por: Caruso, Raffaele, et al.
Publicado: (2015)

Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS Gene Polymorphisms in Atrial Fibrillation Susceptibility
por: Giusti, Betti, et al.
Publicado: (2007)

Platelet Reactivity in Hepatitis C Virus–Infected Patients on Dual Antiplatelet Therapy for Acute Coronary Syndrome
por: Scudiero, Fernando, et al.
Publicado: (2020)

2220: Pharmacogenomic determinants in Caribbean Hispanics of clopidogrel failure in acute coronary syndrome
por: Melin, Kyle, et al.
Publicado: (2018)

Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism
por: Sticchi, Elena, et al.
Publicado: (2016)

Clinical, Pharmacokinetic, and Pharmacogenetic Determinants of Clopidogrel Resistance in Korean Patients with Acute Coronary Syndrome
por: Park, Kyoung-Jin, et al.
Publicado: (2011)

Diffuse prothrombotic syndrome after ChAdOx1 nCoV-19 vaccine administration: a case report
por: Ceschia, Nicole, et al.
Publicado: (2021)

Differential Network Analysis Reveals Metabolic Determinants Associated with Mortality in Acute Myocardial Infarction Patients and Suggests Potential Mechanisms Underlying Different Clinical Scores Used To Predict Death
por: Vignoli, Alessia, et al.
Publicado: (2020)

Quality of life (QOL) evaluation after acute coronary syndrome with simultaneous clopidogrel treatment
por: Chudek, Jerzy, et al.
Publicado: (2013)

Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study
por: Yao, Ying, et al.
Publicado: (2019)

Marfan syndrome: current perspectives
por: Pepe, Guglielmina, et al.
Publicado: (2016)

Comparison of ticagrelor with clopidogrel on quality of life in patients with acute coronary syndrome
por: Moon, Hyeyeon, et al.
Publicado: (2021)

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Norgard, Nicholas B, et al.
Publicado: (2009)

Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience
por: Cesari, Francesca, et al.
Publicado: (2022)

Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
por: Grima, Daniel T, et al.
Publicado: (2014)

Effects of switching ticagrelor to clopidogrel on cardiovascular outcomes in patients with acute coronary syndrome
por: Liu, Lin, et al.
Publicado: (2018)

Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2023)

Sanger Validation of High-Throughput Sequencing in Genetic Diagnosis: Still the Best Practice?
por: De Cario, Rosina, et al.
Publicado: (2020)

Tracking an Elusive Killer: State of the Art of Molecular-Genetic Knowledge and Laboratory Role in Diagnosis and Risk Stratification of Thoracic Aortic Aneurysm and Dissection
por: De Cario, Rosina, et al.
Publicado: (2022)

Effects of vegetarian versus Mediterranean diet on kidney function: Findings from the CARDIVEG study
por: Dinu, Monica, et al.
Publicado: (2021)

Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry
por: Marcucci, Rossella, et al.
Publicado: (2019)

Clinical Implications of “Tailored” Antiplatelet Therapy in Patients With Chronic Total Occlusion
por: De Gregorio, Maria Grazia, et al.
Publicado: (2020)

Effects of Clopidogrel, Prasugrel and Ticagrelor on Microvascular Function and Platelet Reactivity in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Stenting. A Randomized, Blinded, Parallel Group Trial
por: Schnorbus, Boris, et al.
Publicado: (2021)

Effects of switching ticagrelor to clopidogrel on cardiovascular outcomes in patients with acute coronary syndrome: Erratum
Publicado: (2018)

Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis
por: Wang, Dong, et al.
Publicado: (2018)

Comparison of atrial fibrillation predictors in patients with acute coronary syndrome using ticagrelor or clopidogrel
por: ALGÜL, Engin, et al.
Publicado: (2019)

Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes
por: He, Peixun, et al.
Publicado: (2021)

Ticagrelor Versus Clopidogrel in East Asian Patients With Acute Coronary Syndrome and Diabetes Mellitus
por: Choi, Yeonwoo, et al.
Publicado: (2022)

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndrome and on Dialysis: A Meta-Analysis
por: Chenna, Venkata Sai Harshabhargav, et al.
Publicado: (2023)

NMR-based metabolomics identifies patients at high risk of death within two years after acute myocardial infarction in the AMI-Florence II cohort
por: Vignoli, Alessia, et al.
Publicado: (2019)

Optimal Duration for Clopidogrel Suspension Prior to Coronary Artery Bypass Grafting
por: Ullah, Waqas, et al.
Publicado: (2019)

Bleeding events and maintenance dose of prasugrel: BLESS pilot study
por: Carrabba, Nazario, et al.
Publicado: (2016)

Genetic determinants of platelet response to clopidogrel
por: Kubica, Aldona, et al.
Publicado: (2011)

Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry
por: Völz, Sebastian, et al.
Publicado: (2020)

CLOCK gene polymorphisms and quality of aging in a cohort of nonagenarians – The MUGELLO Study
por: Pagliai, Giuditta, et al.
Publicado: (2019)

Lipid and metabolite correlation networks specific to clinical and biochemical covariate show differences associated with sexual dimorphism in a cohort of nonagenarians
por: Di Cesare, Francesca, et al.
Publicado: (2021)

Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap
por: Page, Robert Lee, et al.
Publicado: (2012)

Efficacy and safety outcomes of ticagrelor compared with clopidogrel in elderly Chinese patients with acute coronary syndrome
por: Wang, Huidong, et al.
Publicado: (2016)

Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients
por: Xiao, Fei-Yan, et al.
Publicado: (2017)

Association of GCK gene DNA methylation with the risk of clopidogrel resistance in acute coronary syndrome patients
por: Su, Jia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_skcr2377t63fgemi1s0qj4dbul